SILVER CREEK PHARMACEUTICALS INC has a total of 14 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and micro-structure and nano-technology are Mainline Biosciences, ESBATECH - A NOVARTIS CO LLC and PESTKA BIOMEDICAL LAB INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Hong Kong | 1 | |
#7 | Japan | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Nanostructure applications | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Antipov Laura D J | 7 |
#2 | Onsum Matthew D | 7 |
#3 | Millard Bjorn L | 7 |
#4 | Eshghi Shawdee | 7 |
#5 | Stowe Timothy R | 7 |
#6 | Kuchenbecker Kristopher M | 7 |
#7 | Zhang Yan | 7 |
#8 | Nickerson Andrea D | 7 |
#9 | Linggi Bryan | 5 |
#10 | Harms Brian | 5 |
Publication | Filing date | Title |
---|---|---|
CN108367048A | Bispecific therapeutic protein for tissue repair |